Tau kinases and phosphatases.
作者信息
Avila J
机构信息
Centro de Biología Molecular Severo Ochoa (CSIC-UAM), C/ Nicolás Cabrera, 1 Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
出版信息
J Cell Mol Med. 2008 Jan-Feb;12(1):258-9. doi: 10.1111/j.1582-4934.2007.00214.x.
Abstract
摘要
相似文献
1
Tau kinases and phosphatases.
J Cell Mol Med. 2008 Jan-Feb;12(1):258-9. doi: 10.1111/j.1582-4934.2007.00214.x.
2
Substrate-specific reduction of PP2A activity exaggerates tau pathology.
Biochem Biophys Res Commun. 2009 Feb 6;379(2):400-5. doi: 10.1016/j.bbrc.2008.12.140. Epub 2009 Jan 4.
3
Role of protein phosphatase 2A in Alzheimer's disease.
Curr Alzheimer Res. 2011 Sep;8(6):623-32. doi: 10.2174/156720511796717168.
4
Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
Neurobiol Aging. 2017 Jul;55:202-212. doi: 10.1016/j.neurobiolaging.2017.03.031. Epub 2017 Apr 5.
5
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
J Cell Mol Med. 2008 Jan-Feb;12(1):241-57. doi: 10.1111/j.1582-4934.2008.00249.x. Epub 2008 Jan 19.
6
Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
Brain Res. 1994 May 2;644(2):327-30. doi: 10.1016/0006-8993(94)91697-7.
7
Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
J Mol Neurosci. 2002 Aug-Oct;19(1-2):95-9. doi: 10.1007/s12031-002-0017-3.
8
Cdk5: one of the links between senile plaques and neurofibrillary tangles?
J Alzheimers Dis. 2003 Apr;5(2):127-37. doi: 10.3233/jad-2003-5207.
9
Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals.
Brain Res. 1994 Aug 29;655(1-2):70-6. doi: 10.1016/0006-8993(94)91598-9.
10
Asparagine endopeptidase cleaves tau and promotes neurodegeneration.
Nat Med. 2014 Nov;20(11):1236-8. doi: 10.1038/nm.3749.
引用本文的文献
1
Associations Between Diabetes Mellitus and Neurodegenerative Diseases.
Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.
2
Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments.
Ibrain. 2024 Sep 16;10(4):427-438. doi: 10.1002/ibra.12176. eCollection 2024 Winter.
3
Unraveling the complexity of human brain: Structure, function in healthy and disease states.
Ageing Res Rev. 2024 Sep;100:102414. doi: 10.1016/j.arr.2024.102414. Epub 2024 Jul 15.
4
Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.
Aging Dis. 2024 Apr 23;16(2):1199-1215. doi: 10.14336/AD.2024.0053.
5
Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds.
Int J Mol Sci. 2024 Jan 9;25(2):831. doi: 10.3390/ijms25020831.
6
Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.
Int J Mol Sci. 2022 Oct 25;23(21):12841. doi: 10.3390/ijms232112841.
7
Protective Effect of Natural Antioxidant, Curcumin Nanoparticles, and Zinc Oxide Nanoparticles against Type 2 Diabetes-Promoted Hippocampal Neurotoxicity in Rats.
Pharmaceutics. 2021 Nov 16;13(11):1937. doi: 10.3390/pharmaceutics13111937.
8
Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model .
Front Cell Dev Biol. 2021 Sep 6;9:741662. doi: 10.3389/fcell.2021.741662. eCollection 2021.
9
The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
Cell Commun Signal. 2021 May 1;19(1):49. doi: 10.1186/s12964-021-00736-9.
10
Tau at the interface between neurodegeneration and neuroinflammation.
Genes Immun. 2020 Nov;21(5):288-300. doi: 10.1038/s41435-020-00113-5. Epub 2020 Oct 3.
本文引用的文献
1
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
J Cell Mol Med. 2008 Jan-Feb;12(1):241-57. doi: 10.1111/j.1582-4934.2008.00249.x. Epub 2008 Jan 19.
2
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.
EMBO J. 2007 Dec 12;26(24):5143-52. doi: 10.1038/sj.emboj.7601917. Epub 2007 Nov 15.
3
Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.
J Biol Chem. 2007 Dec 14;282(50):36275-82. doi: 10.1074/jbc.M703561200. Epub 2007 Oct 17.
4
Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.
Mol Biol Cell. 2007 Dec;18(12):5060-8. doi: 10.1091/mbc.e07-04-0327. Epub 2007 Oct 10.
5
Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia.
J Neurosci. 2007 Mar 21;27(12):3090-7. doi: 10.1523/JNEUROSCI.4854-06.2007.
6
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.
Eur J Neurosci. 2005 Oct;22(8):1942-50. doi: 10.1111/j.1460-9568.2005.04391.x.
7
Role of tau protein in both physiological and pathological conditions.
Physiol Rev. 2004 Apr;84(2):361-84. doi: 10.1152/physrev.00024.2003.
8
Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
J Neurosci. 2004 Mar 10;24(10):2401-11. doi: 10.1523/JNEUROSCI.5561-03.2004.
9
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
EMBO J. 2001 Jan 15;20(1-2):27-39. doi: 10.1093/emboj/20.1.27.
10
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
Biochem J. 2001 Feb 1;353(Pt 3):417-39. doi: 10.1042/0264-6021:3530417.
Zotero 插件